FDA Adverse Event Malfunction Summary report: N

LIFESYNC ECG SYSTEM

MDR report key: 966958 · Received December 14, 2007

Report

Report Number
3003829651-2007-00004
Event Type
Malfunction
Date Received
December 14, 2007
Date of Event
March 6, 2007
Report Date
December 14, 2007
Manufacturer
LIFESYNC CORPORATION
Product Code
DRT
Removal / Correction Number
3003829651-01/26/2007-00
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
GA, US
Reporter Occupation
UNKNOWN

Narratives

Additional Manufacturer Narrative · 1

UPON INVESTIGATION OF THE ISSUE, A POSSIBLE ROOT CAUSE WAS DETERMINED. THE TOP INSULATING (PET) LAYER CAN SEPARATE AND TEAR FROM THE UNDERLYING CIRCUIT LAYER, WHEN TRYING TO PULL THE V-LEAD AWAY FROM ITS PERFORATIONS. ALL LOTS ASSOCIATED WITH THIS FAILURE MODE WERE REMOVED FROM THE FIELD. NO HARM WAS CAUSED TO THE PT AS A RESULT OF THIS INCIDENT. HOWEVER, UPON RETROSPECTIVE REVIEW OF THIS ISSUE, THE POTENTIAL FOR HARM WAS IDENTIFIED AND THE INCIDENT HAS BEEN DEEMED REPORTABLE.

Description of Event or Problem · 1

THE CUSTOMER INDICATED THAT LIFESYNC LEADWEAR DISPOSABLE MODEL NO LS-222 LOT # 002308-S DID NOT WORK OUT OF THE BOX. FURTHER INVESTIGATION PERFORMED BY THE MANUFACTURER DETERMINED THAT HANDLING OF THE PRODUCT AND DELAMINATION OF THE PET LAYER LEAD TO FRACTURE IN THE DIELECTRIC INK AND LOSS OF CONTINUITY. THE LOSS OF CONTINUITY RESULTED IN THE BEHAVIOR NOTED BY THE CUSTOMER. A HEALTH HAZARD EVALUATION WAS PERFORMED REGARDING THE FAILURE MODE. IT WAS DETERMINED THAT A TEAR IN THE LAMINATE COULD EXPOSE THE DIALECTRIC LAYER, CAUSING A "BREAK" IN THE SILVER INK. IF DEFIBRILLATION WAS PERFORMED AFTER SUCH A DE-LAMINATION, IT COULD INTRODUCE HIGHER THAN NORMAL HEAT TO THE SKIN, POSSIBLY LEADING TO BURNS, AND MAY COMPROMISE THE EFFICACY OF THE DEFIBRILLATION. NO HARM WAS CAUSED TO THE PT AS A RESULT OF THIS INCIDENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 LIFESYNC ECG SYSTEM WIRELESS ECG SYSTEM DRT LIFESYNC CORPORATION LS-222 002308 S

Patients

Seq Age Sex Outcome Treatment
1 YR